Objectives: To perform a multifactorial exploration of the aetiology of peritonsillar abscess (PTA) in adults, in order to develop greater clinical understanding of the condition and improve management.
Introduction
Peritonsillar abscess (PTA)-also known as 'quinsy'-is a localized deep neck infection that develops between the tonsil and its capsule. 1 -3 The infection can progress to airway obstruction, abscess rupture and asphyxia by aspiration of pus and necrosis resulting in septicaemia or haemorrhage. 4, 5 English data from the year 2009-10 saw 7589 finished consultant episodes attributed to PTA, and the condition is on the rise. 4, 6, 7 There is very little understanding of the disease's aetiology 6, 8 as highlighted by the lack of management protocols. 7 Treatments vary greatly between clinicians, ranging across antibiotics + surgical drainage + removal of the palatine tonsils. 7, 9, 10 PTA is commonly stated to be a complication of acute tonsillitis (AT); 11 recent reports, however, suggest that primary tonsillitis may not always be the causative factor. The pathogenesis requires certain microfloral compositions coinciding with oropharyngeal damage and/or immunocompromise. 12 -14 This review attempts to explore these controversies with a view to improving understanding of the disease, standardizing management and generating strategies for its prevention.
We reviewed the literature to identify probable pathogens and critically analysed the evidence behind current hypotheses on the pathogenesis of PTA.
Methods
The literature was reviewed using the PubMed database, searching for papers published between January 1980 and January 2012. Search terms were 'peritonsillar abscess AND microbiology', 'peritonsillar abscess AND pathophysiology' and 'peritonsillar abscess AND etiology'. Of the 668 results obtained, 112 titles were deemed to be relevant to the pathogenesis and incidence of PTA in adults. Relevance when reading abstracts was further assessed using an inclusion criterion ( Figure 1) ; this resulted in 58 appropriate sources. References within the bibliographies of these articles were then tracked.
Results

PTA microbiology
Microbiological overview
There is much inconsistency and controversy across the literature in describing the microbiology of PTA. Table 1 displays the diverse range of microbiological findings obtained from PTA pus samples that were analysed in 15 papers. 8,15 -28 This is likely to reflect the substantial diversity of natural flora within the oropharyngeal spaces. The majority of PTAs, in most series, are polymicrobial infections containing common oropharyngeal microflora, 5, 15, 16, 22, 30, 31 with an average of three isolates per specimen. 15, 16, 19 However, Megalamani et al. 32 describe all their identified aerobic infections (65% of their isolated cultures) as being monomicrobial, and 72.3% of the patients studied by Snow et al. 17 also had monomicrobial infections.
Determination of PTA pathogens: methodological considerations
The extreme variation observed in Table 1 may reflect methodological differences between the studies reviewed. Different culturing techniques, incubation times, sample origins and collection methods could significantly alter the validity of the findings as a true representation of the isolates found at the site of infection. 21, 33 The method of recording microbiological findings may also influence the results. Whether facultative anaerobes were classified as aerobes or anaerobes varied across studies. 19, 25 Some studies used species growth as a indication of pathogenesis and recorded only those with moderate to heavy growth. 19 More virulent PTA pathogens with less growth might have been overlooked. 15, 25, 34 Alternatively, data variations could have occurred due to the different geographical locations of the studies. The microflora of individual populations may differ significantly owing to native diets and lifestyles. 21 Klug et al. 26, 35 and Rusan et al. recorded particularly high levels of Fusobacterium but gathered all of their data from a Danish population, which may have higher microfloral Fusobacterium levels than other populations. Another important variable was that patients presenting with PTA were at different stages of antimicrobial therapy. The majority of patients had been prescribed antibiotics on primary presentation to their GP, which may have altered the findings. Some studies have reported no significant difference in microflora between patients with prior antibiotic treatment and those without. 18, 21, 27, 32 Microbiological analyses by Megalamani et al. 32 used only patients without prior antibiotic treatment and gained percentages of isolates of group A streptococci (GAS) similar to those noted in patients who had had antibiotic pretreatment. Conversely, some studies found that the incidence of GAS infections was significantly reduced in patients pretreated with antimicrobial agents. 15, 19 These studies suggest that GAS could be the causative organism in far more cases of PTA than have been recorded, but that the use of antimicrobials kills the pathogen, allowing resistant commensals to invade the damaged tissue space. 15, 18, 19, 36 Major pathogens in PTA In PTAs yielding a single isolate, GAS and Fusobacterium necrophorum were the most commonly isolated organisms. 8,17 -19,26,27,31,32,35,36 Klug et al. 26 and Rusan et al. 36 showed that F. necrophorum and GAS were significantly more prevalent in the tonsils of their patients with PTA than in tonsils excised electively from patients with chronic tonsillar disease. Pure cultures containing Streptococcus milleri group (SMG), Staphylococcus aureus, Nocardia asteroides, Haemophilus influenzae, Arcanobacterium haemolyticum and Streptococcus pneumoniae have also been recorded. 15 -19,31,33,37,38 These findings suggest a role for them as primary pathogens.
It is a difficult task to determine which of the identified strains prevalent in polymicrobial samples is a significant pathogen. In the literature, three opportunistic bacteria yielding heavy growth from aspirates have been considered to be key causative organisms: GAS, indigenous Fusobacterium species and SMG. 8, 15, 18, 25, 26 While the heavy growth of group C streptococci, Peptostreptococcus and Prevotella species is commonly observed in PTA aspirates, these organisms have received very little attention within the literature and hence will not be addressed in detail here. 15, 16, 22, 25, 31 GAS Microbiological analyses show that between 20% and 30% of PTAs are caused by GAS, while in some studies GAS have been Various studies 17, 18, 31, 32 have observed GAS growing in pure culture more often than in mixed culture: Lilja et al. 31 found GAS to be present only in monomicrobial PTA samples. GAS are consistently the isolate most commonly recovered from monomicrobial PTAs. The prevalence of GAS in aspirates is higher than that in patients with little or no history of sore throat: Jousimies-Somer et al. 18 found, in a series of 550 aspirates, that the rate of previous peritonsillar or tonsillar infection was significantly lower (P,0.01) in GAS-harbouring patients than in those with anaerobic infections. Despite the high incidence of GAS in PTAs, its causative relationship has not been fully identified. Risberg et al. 39 found that those presenting with PTA had no significant excess of GAS-positive results compared with those presenting with sore throat. This would suggest the involvement of other co-factors in the pathogenesis of PTA.
Fusobacterium species F. necrophorum is the anaerobe most commonly found in pure culture in PTA. 8, 19, 26, 35 This obligate anaerobe has been linked to a variety of localized head and neck infections as well as Lemierre's syndrome. 40, 41 Studies have observed Fusobacterium in 4%-53% of samples, often reporting higher isolate numbers than for GAS. 8, 18, 19, 25, 26, 33, 35, 40 The capability of Fusobacterium to be a significant pathogen in PTA has been highlighted in a number of studies. 35, 40, 42 Klug et al. 35 observed that 81% of F. necrophorum isolates grew as a pure culture, and that colonized patients harbouring these isolates had significantly stronger inflammatory responses to the PTA infection. Brook et al. 42 showed that F. nucleatum could be isolated from the PTAs of 74% of a series of paediatric patients. Furthermore, this study found higher levels of antibodies to both F. nucleatum and Prevotella intermedia in patients with PTA than healthy controls, highlighting a probable pathogenic interaction of these organisms with their host. 42 This evidence must take into the fact that microbial compositions and distributions may vary significantly with age due to growth, lifestyle and hormonal changes.
Patients with a history of recurrent sore throat prior to the development of PTA were found to be more likely to have anaerobic infections containing Fusobacterium. 18 This bacterium has also been isolated from patients presenting with recurrent AT, persistent sore throat syndrome, pharyngitis and hypertrophic tonsils. 41, 43, 44 It may be that the species favours conditions that could potentially exist in all of these throat problems.
Fusobacterium species clearly have a pathogenic role in the development of PTA, especially within polymicrobial infections. Their apparent involvement as pathogens in other throat infections suggests that co-factors are necessary to promote the localized tissue invasion required for PTA.
SMG The facultative anaerobic group of commensal SMG consists of three species: Streptococcus intermedius, Streptococcus anginosus and Streptococcus constellatus. SMG has been associated with a range of serious head and neck infections and is commonly associated with abscess formation. 45, 46 Saiki et al. 47 identified SMG isolates as making up 28% of their total isolates, findings supported by Hidaka et al., 25 Jousimies-Somer et al.
18
and Fujiyoshi et al., 48 for whom SMG was the most common species isolated (25.8%). 48 Mitchelmore et al. 19 recorded SMG in 51% of samples. SMG most commonly coexists with anaerobes. Jousimies-Somer et al. 18 observed that SMG was 'always in mixed culture', although Hidaka et al. 25 obtained aspirate cultures with pure SMG isolates. SMG thrives within polymicrobial infections and is thought to promote virulence and accelerate inflammation. 19, 25, 45 Given these findings, SMG is likely to have a pathogenic role in the development of PTA.
We have clearly identified three key opportunistic bacteria that are likely to be causative organisms in PTA: GAS, indigenous Fusobacterium species and SMG. There seem to be predominantly two pathogenically different PTA subtypes. Type 1 contains a pure culture of a single organism, most often GAS. Type 2 displays heavy polymicrobial growth, often containing a variety of facultative and obligate anaerobes. Clinically, type 2 PTA often appears to be more severe, probably due to synergistic microbial interactions. 15, 49 The history of recurrent sore throat observed in patients presenting with type 2 PTA is possibly representative of a chronic underlying microfloral imbalance. 18, 23 PTA pathogenesis
Current hypotheses
Two hypotheses are currently described to explain the pathogenesis of PTA. The predominant theory-described in the majority of medical textbooks and hence well known among clinicians-states that PTA is a complication of AT. 11 There seems, however, to be no scientific literature that provides direct supporting evidence for this. The second is a hypothesis that has been slowly gathering more recognition and supporting evidence over the last 20 years and highlights the association between damaged tissue and abscess development: the 'Weber gland hypothesis'.
A complication of AT
Recurrent episodes of ATand sore throat are commonly reported in PTA. 19, 50 Marom et al. 50 found that 79% of patients in their study reported a sore throat preceding the development of PTA. However, other studies have reported that up to 68% of patients with PTA have no preceding history of tonsillitis or sore throat. 22, 50, 51 Some other recent observations question the true involvement of AT in the development of PTA. 12 -14 First, Passy 12 observed in a study of 100 consecutive PTA patients that 96% of patients had no exudate on the tonsils and very little tonsillar swelling. Furthermore, a study of resected tonsils by Chen et al.
14 showed that the tonsils of patients with PTA were smooth and healthy, while fibrosis was noted in the surrounding tissue. Considering the bacteriology, isolates commonly found in PTA are also found in the oropharynx of patients with AT and recurrent AT. 52 -54 As in PTA, there is great variation in the oropharyngeal bacteriology related to AT and recurrent AT. 52, 53, 55 GAS are found in statistically similar numbers, 52 and anaerobic microflora are becoming more recognized as potential causes of these diseases. 53, 54 However, other studies indicate significantly more growth of S. aureus and H. influenza in the tonsils of patients with AT than in those with PTA. 52, 55 A further area of discrepancy concerns the modal peak of incidence groups with the highest diagnoses of AT and PTA. The incidence of PTA is highest from the mid-teens to 40 years Review old. 4,12,22,27,56 -58 AT, on the other hand, has its highest incidence at ages 5-15. 12 One would have expected an overlap between these age bands if PTA was indeed a direct complication of AT. Furthermore, the average times to onset of symptoms are similar in PTA and AT (3 -5 days), which also makes it seem unlikely that PTA is a progression of AT. 12, 25 Investigating the seasonal incidence of PTA in relation to AT, Kordeluk et al. 59 found no correlational lag between outbreaks of AT and PTA. Rather, AT and PTA were observed to peak simultaneously. However, this could be due to a common causal factor such as an environmental condition or pathogen that has the capability to induce both throat conditions. 59 Ong et al. 58 found no consistent seasonal correlation between the incidence of PTA and other upper respiratory tract infections.
Blocked Weber glands
Passy 12 hypothesized that PTA results from damage to the salivary glands of the upper soft palate known as the Weber glands. These glands are proximal to the palatine tonsils and help to keep the peritonsillar niche and tonsil crypts clean. The resected tonsil study of Chen et al.
14 found that although the upper tonsils were smooth and healthy, there was inflammation and minor fibrosis of the adjacent Weber glands. Both Brook 5 and Passy 12 suggest that localized Weber gland infection or poor dental hygiene could lead to scarring and subsequent blockage of the gland or the draining duct. A reduction in the production of saliva could increase the chances of suppuration within the tonsillar crypts and oral scar tissue, providing opportunity for localized peritonsillar infection. Saliva is also known to contain elements of the innate immune system that control the resident microflora; 60 a blockage could potentially result in less control over opportunists. Although this is a plausible theory, Dang et al. 61 performed a prospective cohort study that found no correlation between salivary flow rate and PTA.
Host factors associated with PTA
The key pathogens in PTA are resident microflora. In order to cause PTA, opportunists need to overcome the homeostatic nature of the commensal-host relationship within the oropharynx. There are several host factors that may promote PTA, such as age (mid-teens to 40 years), male gender, periodontal disease, smoking, compromised immunity and previous antibiotic use 4 -6,8,10,12,14,19,22,23,25,27,35,40,41,43,46,48,50 -52,56 -60,62 -89 ( Table 2 ). These in turn influence other factors: conditions for the growth of opportunists, local humoral immunity, routes for microbial invasion and niches for trapped debris, microbial growth and localized suppuration.
Host immunity and PTA
PTA has been identified as a comorbidity factor often associated with viral infection suppressing or compromising host immunity, allowing for opportunistic secondary infection. 50,84,89 -91 Between January 2006 and December 2007, Ahmad and Anari 84 recorded infectious mononucleosis (IM) in 4% of patients with PTA admitted to the Freeman Hospital, Newcastle upon Tyne. Some small-scale studies have shown comorbidity rates of IM with PTA to be as high as 20%. 84 The compromised humoral immunity of these patients allows opportunists to adhere to the host's tonsillar tissue and subsequently invade the epithelia, clinically seen as the progression of membranous tonsillitis to PTA. 89 It has been hypothesized that patients reporting non-exudative tonsillitis prior to the development of PTA may have a localized viral infection, compromising the local immune system and allowing bacterial invasion. A report of entirely viral PTA supports this hypothesis. 92 However, the recent study of Rusan et al. 36 investigating viral incidence and PTA showed no significant difference in the viral load of patients with PTA compared with that in the tonsils of patients with chronic tonsillar disease.
Lilja et al. 31 found that most bacteria recovered from PTA pus were not opsonized by complement components or immunoglobulin (Ig). In comparison, bacteria from the surfaces of healthy tonsils were coated by surface IgA. None of the infecting organisms from monomicrobial PTA samples was host immunelabelled. The group consistently noticed build-ups of deformed and apoptotic host immune cells at the PTA site, occurring with particular severity when GAS were also present. Their justification for their findings includes: † PTA pathogens may produce proteolytic enzymes that outcompete and over-ride host local immunity. 31 † There is possible support for Passy's Weber gland hypothesis. These glands secrete IgA; blockage may lead to decreased IgA production, which may subsequently allow for growth of and invasion by pathogens. 31 There appears to be no other literature investigating the expression or interaction of local immune system components and the development of PTA. There is, however, evidence relative to other throat infections. Tonsillar human b-defensin (HBD) levels, for example, have been shown to be significantly reduced in patients with recurrent tonsillitis. 60, 74, 87 Besides producing immunomodulatory proteins, the tonsillar tissue also acts as a site for antigen sampling. 93 Damage or blockage of these sampling sites-as a result of debris or damaging habits such as smoking-may affect the ability of receptors to recognize pathogens and manifest an immune response. 68, 70, 79, 93 
Implications for clinical practice
This review supports the current practice of administering combined antibiotics to patients with PTA. 7 Furthermore, it supports guidelines from the Scottish Intercollegiate Guidelines Network not to prescribe antibiotics to patients presenting with uncomplicated sore throat, with the risk of promoting a polymicrobial anaerobic (type 2) PTA or switching a streptococcal infection into an infection with more severe type 2 characteristics. 94 Patients presenting with a history of chronic sore throat should be monitored following management of PTA and steps should be taken to address lifestyle choices that may potentially be promoting microfloral imbalance and susceptibility to infection. We suggest attempting this non-invasive, cost-effective form of management before considering more interventional procedures such as tonsillectomy.
Understanding factors that promote the growth and colonization of key PTA pathogens should not only lead to a more effective and standardized management of PTA, but also provide hormonal effect on local immunity and/or microfloral composition (8, 57) lower incidences of GAS infections in those over 40 years of age (8) highest incidence of fusobacterial PTA infections is in young adults (35) lifestyle high incidence of other fusobacterial infections in young adults (8, 42, 44, 64) tonsillar crypt size (41) Gender higher PTA incidence in males than females in a 3: 1 ratio retrospectively for: (27, 58, 63, 65) males have larger oropharyngeal features (41) ear/nose/throat GAS infections are more common in males than females (8) fusobacterial infections suggested to be more common in males (8, 64) high incidence of SMG infections in males (25, 47) against (gender as a non-significant factor): (36, 56, 57, 59, 62) females have better oropharyngeal immunity prior to middle age (66) lifestyle ( (5, 69, 71, 72, 80) opportunity for disease prevention. Re-educating clinicians about the pathogenesis of PTA will increase awareness of the risk factors, identifying high-risk groups while dismissing misconceptions that PTA is purely a complication of AT. Individuals presenting to primary care with chronic throat problems are potentially identifiable as being at 'high risk of PTA'. By addressing the patient's lifestyle, steps can be taken to monitor and reduce the risk of abscess development.
With increasing evidence of links between poor oral hygiene and throat infections such as PTA, it is perhaps time for a more communal approach to the monitoring, care and education of patients in which dentists and doctors collaborate further.
Further research
Standardizing PTA pus sample analysis would provide more comparable, reliable microbiological data. The use of highly sensitive, modern analytic tests such as PCR should identify the true PTA microfloral composition more reliably. 95 PCR of peritonsillar swabs from healthy volunteers could provide comparative control data to then determine the probable pathogens-possibly a more valid method than investigating the microflora of tonsils excised from elective tonsillectomy patients, samples that are unlikely to be representative of healthy individuals. Immune assays of patients with PTA may allow for a more conclusive identification of pathogenic species. 42 More data from a wider cultural and populational spread would permit for a more viable dataset and fairer analysis.
Investigating patients' symptoms, sore throat experience and history in relation to the microbiology of PTA could provide more conclusive evidence in support of our proposal that there are subtypes of PTA. Grouping patients into microbiologically similar subtypes might allow for a more appropriate and more efficient management.
Designing a tool that assesses throat health could be of use both for disease prevention and for monitoring the efficacy of PTA management. Our team have recently explored the use of the Tonsillectomy Outcome Inventory 14 as such a tool, with positive outcomes for scoring throat-related quality of life. 96 
Conclusions
We have identified pathogens in PTA that are opportunistic species native to the oropharynx. With the rapid evolution of generational behaviour and lifestyle, it is likely that microfloral compositions are continually changing. Therefore, it is probable that the organisms considered to be major pathogens associated with PTA will fluctuate and change. For example, it has been suggested that the increased prescription and dosage of b-lactamases is encouraging pathogenic behaviour on the part of anaerobes. 19 It is unclear whether the rise in anaerobic infections seen in recent years is linked to changes such as these or whether it is related to more sensitive tests that actively search and identify species that have been ever-present. Patients' experience and history of sore throat appear to differ according to whether their PTA is a monomicrobial aerobic infection or a polymicrobial infection containing anaerobes. This leads us to propose that there may be pathogenically distinct PTA subtypes.
The establishment of PTA ultimately requires the disruption of oropharyngeal commensal-host homeostasis followed by Compromised immunity comorbidity factor: high incidence of PTA in patients with IM and Kawasaki's disease (36, 85 -87) compromised humoral immunity allowing tissue invasion (90) contrary to control data, HBD-1 expression in tonsils from patients with recurrent AT is not significantly increased when challenged with GAS (88) evidence of genetic susceptibility to other throat infections such as recurrent tonsillitis (60, 75, 88, 89) inflammation as a result of superficial infection can lead to increased access of pathogens (87) poor humoral response to pathogen, allowing growth (30, 60, 88) Antibiotic use increased incidence of PTA correlates with increased prescribed antibiotics for sore throat (19, 51) pathogen switch: kill/inhibit original pathogen allowing resistant, potentially more virulent species to invade suggested that antibiotic use promotes pathogenicity (49) promote growth and pathogenesis of b-lactamase opportunists (19) encourages bacteria to invade tonsillar tissue (51) Parentheses denote reference numbers for sources of evidence.
Review 1947 JAC localized tissue invasion. Certain host factors influence the development of PTA; some are controllable and therefore clinically targetable, whereas others are uncontrollable risk factors that may be used by clinicians to indicate overall patient susceptibility ( Figure 2 ). Current hypotheses concerning the pathogenesis of PTA are likely to have some validity. Mild suppurative infection, such as AT, could spread and result in tissue damage allowing localized invasion by the already established pathogen. Blocked Weber glands could lead to increased debris in the tonsillar crypts, subsequent poor oral hygiene and niches for suppuration. The number of factors and variables affecting the development of PTA, however, suggests that the combination of a variety of circumstances can trigger pathogenesis. It would seem that PTA is, more often than not, a pathogenically separate entity from AT.
With the incidence of PTA rising worldwide and an increased understanding of its aetiology, it is important to focus attention on disease prevention in addition to appropriate management. Re-education concerning the range of factors that promote pathogenesis and invasion in PTA may facilitate disease prevention.
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